Archive for the ‘nature publishing group’ Category
Another stem cell paper has been retracted from Nature, this one a highly cited 2008 study that had already been the subject of what the journal’s news section called a “furore” in 2010.
According to that 2010 news story:
The researchers behind the original work1, led by Thomas Skutella of the University of Tübingen, reported using cells from adult human testes to create pluripotent stem cells with similar properties to embryonic stem cells.
But a 2010 Brief Communication Arising called those findings into question. And now, the authors have retracted the paper. Here’s the notice for “Generation of pluripotent stem cells from adult human testis:” Read the rest of this entry »
STAP stem cell papers officially retracted as Nature argues peer review couldn’t have detected fatal problems
A significant chapter of the nearly six-month saga of the STAP stem cell controversy has come to an end, with Nature running retraction notices for the two papers involved. The journal has also published an editorial about the case that’s worth a read.
The retractions for “Bidirectional developmental potential in reprogrammed cells with acquired pluripotency” and “Stimulus-triggered fate conversion of somatic cells into pluripotency” both read: Read the rest of this entry »
Here’s the notice for “Clinical significance of p95HER2 overexpression, PTEN loss and PI3K expression in p185HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies:” Read the rest of this entry »
A group at the University of Texas Southwestern led by Adi F. Gazdar that found evidence of inappropriate image manipulation in a number of their papers has retracted its seventh and eighth studies.